Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20260815070653N1Phase 3Recruiting
Phase 3, randomised, double-blind trial comparing Remifentanil group with Ketamine group (2 arms). Primary endpoints: Hemodynamic responses, Pain intensity and 2 more. Started Sep 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20260815070653N1.